Search Results - Modi, Marlene

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Use of peginterferon alfa-2a (40 KD) (Pegasys ®) for the treatment of hepatitis C

    Use of peginterferon alfa-2a (40 KD) (Pegasys ®) for the treatment of hepatitis C by Rajender Reddy, K., Modi, Marlene W., Pedder, Simon

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C

    Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C by Bailon, Pascal, Palleroni, Alicia, Schaffer, Carol A, Spence, Cheryl L, Fung, Wen-Jian, Porter, Jill E, Ehrlich, George K, Pan, Wen, Xu, Zhi-Xin, Modi, Marlene W, Farid, Adrienne, Berthold, Wolfgang, Graves, Mary

    Published in Bioconjugate chemistry
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Pegylation: A novel process for modifying pharmacokinetics

    Pegylation: A novel process for modifying pharmacokinetics by HARRIS, J. Milton, MARTIN, Nancy E, MODI, Marlene

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia

    Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia by Steinberg, Gary K., Panahian, Nariman, Pérez-Pinzón, Miguel A., Sun, Guo-Hua, Modi, Marlene W., Sepinwall, Jerry

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C: Peptide and protein pegylation

    Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C: Peptide and protein pegylation by REDDY, K. Rajender, MODI, Marlene W, PEDDER, Simon

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast

    Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast by ÄDELROTH, E, INMAN, M. D, SUMMERS, E, PACE, D, MODI, M, O'BYRNE, P. M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D 4–receptor antagonist cinalukast

    Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D 4–receptor antagonist cinalukast by Ädelroth, Ellinor, Inman, Mark D., Summers a, Edie, Pace, Dan, Modi, Marlene, O'Byrne, Paul M.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon a-2a for the Treatment of Hepatitis C

    Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon a-2a for the Treatment of Hepatitis C by Pascal Bailon, Pascal Bailon Alicia Palleroni, Schaffer, Carol A, Spence, Cheryl L, Fung, Wen-Jian, Porter, Jill E, Ehrlich, George K, Pan, Wen, Xu, Zhi-Xin, Modi, Marlene W, Farid, Adrienne, Berthold, Wolfgang

    Published in Bioconjugate chemistry
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    EUROPEAN ASSOCIATION OF PERINATAL MEDICINE (EAPM) EUROPEAN MIDWIVES ASSOCIATION (EMA) Joint position statement: Caesarean delivery rates at a country level should be in the 15-20 % range

    EUROPEAN ASSOCIATION OF PERINATAL MEDICINE (EAPM) EUROPEAN MIDWIVES ASSOCIATION (EMA) Joint position statement: Caesarean delivery rates at a country level should be in the 15-20 %... by Ayres-de-Campos, Diogo, Simon, Agnes, Modi, Neena, Tudose, Melania, Saliba, Elie, Wielgos, Miroslaw, Reyns, Marlene, Athanasiadis, Apostolos, Stenback, Pernila, Verlohren, Stefan, Nikolova, Gergana, Lopriore, Enrico, Yurtsal, Burçu, Pellicer, Adelina, Ramenghi, Luca, Jacobsson, Bo

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  10. 10
    European Association of Perinatal Medicine (EAPM), European Board and College of Obstetricians and Gynaecologists (EBCOG), European Midwives Association (EMA). Joint position statement: Substandard and disrespectful care in labour – because words matter

    European Association of Perinatal Medicine (EAPM), European Board and College of Obstetricians and Gynaecologists (EBCOG), European Midwives Association (EMA). Joint position state... by Ayres-de-Campos, Diogo, Louwen, Frank, Vivilaki, Victoria, Benedetto, Chiara, Modi, Neena, Wielgos, Miroslaw, Tudose, Melania-Elena Pop, Timonen, Susanna, Reyns, Marlene, Yli, Branka, Stenback, Pernilla, Nunes, Inês, Yurtsal, Burcu, Vayssière, Christophe, Roth, Georges-Emmanuel, Jonsson, Maria, Bakker, Petra, Lopriore, Enrico, Verlohren, Stefan, Jacobsson, Bo

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    EUROPEAN ASSOCIATION OF PERINATAL MEDICINE (EAPM) EUROPEAN MIDWIVES ASSOCIATION (EMA)

    EUROPEAN ASSOCIATION OF PERINATAL MEDICINE (EAPM) EUROPEAN MIDWIVES ASSOCIATION (EMA) by Ayres-de-Campos, Diogo, Simon, Agnes, Modi, Neena, Tudose, Melania, Saliba, Elie, Wielgos, Miroslaw, Reyns, Marlene, Athanasiadis, Apostolos, Stenback, Pernila, Verlohren, Stefan, Nikolova, Gergana, Lopriore, Enrico, Yurtsal, Burçu, Pellicer, Adelina, Ramenghi, Luca, Jacobsson, Bo

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: